Third paragraph http://ir.organovo.com/news/press-releases/press-releases-details/2014/Organovo-Comments-on-Misleading-and-Inaccurate-Reports/default.aspx Second question http://www.organovo.com/investors/frequently-asked-questions
Organovo: 3 Things to Know
3 Things You Need to Know
On one hand…
In April, the company
said many short attacks
The company filed a libel
lawsuit against one
research firm putting out
While the facts being used
might be in question,
there’s no doubt this is a
Essentially no product
revenue has ever been
Management has had a
number of dilutive
On the other…
Organovo was expected to finish functional validation
of its 3-D liver assays in March, and have them to Key
Opinion Leaders (KOLs) by April.
The company reached both of those goals by late
Demand has been strong enough for these assays that
the company is conducting liver toxicity tests for
selected customers ahead of the product’s December
Organovo has not provided a timeline for when KOL
findings will be released.
However, since the liver assays will launch prior to
2015, KOL opinions will likely be released before that
Investors likely won’t get a chance to see revenue
numbers before mid-2015 earnings are released, so
these KOL opinions will have a major impact on the
company’s stock…and the investment thesis for
Investing in cutting-edge companies like Organovo is
fun, but such speculative companies alone shouldn’t
dominate your portfolio.
To get a list of solid, steady, dividend payers, check out
our special free report:
Top Dividend Stocks for the Next
A particular slide catching your eye?
Clipping is a handy way to collect important slides you want to go back to later.